Arm shot may boost walking after stroke
NCT ID NCT04908423
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether injecting Xeomin® into the upper arm can improve walking and quality of life in adults who have weakness on one side after a stroke. Twenty participants will be measured before and 4-6 weeks after the injection using walking tests and a sensor. The goal is to see if treating arm spasticity has a ripple effect on mobility.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Xeomin® (incobotulinumtoxinA, a botulinum toxin type A)
- What this could lead to
- If it works, this could point toward a way to improve walking and daily function for stroke survivors with arm spasticity.
- What could go wrong
- This is a small pilot study with only 20 people, so results may not apply widely. The injection is in the arm, so any walking benefit is indirect and uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Carolinas Rehabilitation
RECRUITINGCharlotte, North Carolina, 28203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal zaps could reboot breathing after brain injury
- Can brain scans reveal hidden language struggles after stroke?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- A tablet test aims to catch hidden attention and memory problems after stroke
- Can a gentle ear zap supercharge stroke rehab at home?
- Can exercise boost reading recovery in stroke survivors?